Version 1
: Received: 2 November 2021 / Approved: 3 November 2021 / Online: 3 November 2021 (16:16:42 CET)
Version 2
: Received: 11 November 2021 / Approved: 12 November 2021 / Online: 12 November 2021 (11:44:31 CET)
Furia, J. P.; Lundeen, M. A.; Hurd, J. L.; Pearce, D. A.; Alt, C.; Alt, E. U.; Schmitz, C.; Maffulli, N. Why and How to Use the Body’s Own Stem Cells for Regeneration in Musculoskeletal Disorders: A Primer. Journal of Orthopaedic Surgery and Research, 2022, 17. https://doi.org/10.1186/s13018-022-02918-8.
Furia, J. P.; Lundeen, M. A.; Hurd, J. L.; Pearce, D. A.; Alt, C.; Alt, E. U.; Schmitz, C.; Maffulli, N. Why and How to Use the Body’s Own Stem Cells for Regeneration in Musculoskeletal Disorders: A Primer. Journal of Orthopaedic Surgery and Research, 2022, 17. https://doi.org/10.1186/s13018-022-02918-8.
Furia, J. P.; Lundeen, M. A.; Hurd, J. L.; Pearce, D. A.; Alt, C.; Alt, E. U.; Schmitz, C.; Maffulli, N. Why and How to Use the Body’s Own Stem Cells for Regeneration in Musculoskeletal Disorders: A Primer. Journal of Orthopaedic Surgery and Research, 2022, 17. https://doi.org/10.1186/s13018-022-02918-8.
Furia, J. P.; Lundeen, M. A.; Hurd, J. L.; Pearce, D. A.; Alt, C.; Alt, E. U.; Schmitz, C.; Maffulli, N. Why and How to Use the Body’s Own Stem Cells for Regeneration in Musculoskeletal Disorders: A Primer. Journal of Orthopaedic Surgery and Research, 2022, 17. https://doi.org/10.1186/s13018-022-02918-8.
Abstract
Background: Recently, the management of musculoskeletal disorders with the patients' own stem cells, isolated from the walls of small blood vessels, which can be found in great numbers in the adipose tissue, has received considerable attention. On the other hand, there are still misconceptions about these adipose-derived regenerative cells (ADRCs) that contain vascular-associated pluripotent stem cells (vaPS cells) in regenerative medicine. Methods: Based on our previous publications on this topic, we have developed a concept to describe the significance of the ADRCs/vaPS cells in the field of orthobiologics as briefly as possible and at the same time as precisely as possible. Results: The ADRCs/vaPS cells belong to the group of orthobiologics that are based on autologous cells. Because the latter can both stimulate a patient’s body's localized self-healing power and provide new cells that can integrate into the host tissue during the healing response when the localized self-healing power is exhausted, this group of orthobiologics appears more advantageous than cell-free orthobiologics and orthobiologics that are based on allogeneic cells. Within the group of orthobiologics that are based on autologous cells, enzymatically isolated, uncultured ADRCs/vaPS cells have several advantages over non-enzymatically isolated cells/microfragmented fat as well as over uncultured bone marrow aspirate concentrate and cultured cells (adipose-derived stem cells, bone marrow-derived mesenchymal stem cells). Conclusions: The use of ADRCs/vaPS cells can be seamlessly integrated into modern orthopedic treatment concepts, which can be understood as the optimization of a process which - albeit less efficiently - also takes place physiologically. Accordingly, this new safe and effective type of treatment is attractive in terms of holistic thinking and personalized medicine.
Keywords
adipose-derived regenerative cells; ADRCs; adipose-derived stem cells; ADSCs; bone regeneration, cartilage regeneration; efficacy; point of care treatment; stem cell; tendon healing without scar formation; tendon regeneration; vaPS cells
Subject
Medicine and Pharmacology, Orthopedics and Sports Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
Commenter: Christoph Schmitz
Commenter's Conflict of Interests: Author